Optimal blood pressure control
The SPRINT study
Notes
Einhaltung ethischer Richtlinien
Interessenkonflikt
T. Philipp und S. Nitschmann geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Literatur
- 1.Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 Diabetes mellitus. N Engl J Med. 2010;362:1575–1585.CrossRefPubMedGoogle Scholar
- 2.Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment randomised trial. Lancet. 1998;351:1755–1762.CrossRefPubMedGoogle Scholar
- 3.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. JAMA. 1991;265:3255–3264.CrossRefGoogle Scholar
- 4.Staessen JA, Fagard R, Thijs I, et al. Randomized double-blind comparison or placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757–764.CrossRefPubMedGoogle Scholar
- 5.Sundström J, Arima H, Jackson R, et al. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med. 2015;162:184–191.CrossRefPubMedGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 2016